世邦魏理仕：2026年美国生命科学地产趋势研究报告（英文版）（25页）.pdf

1、2026 U.S.Life Sciences TrendsForces Driving a RecoveryCBRE RESEARCHMARCH 2026Intelligent InvestmentREPORT 2CBRE RESEARCH 2026 CBRE,INC.Intelligent Investment 2026 U.S.Life Sciences TrendsForces Driving a Recovery in 2026 1Construction will drop to decade-low levels amid stable demand Lab/R&D constru

2、ction activity will decline by 87%between Q4 2025 and Q4 2026,nearly emptying the future supply pipeline,balancing supply and demand and improving market conditions.2Capital markets signal upside for lab/R&D demandLife sciences equity market indicators and venture capital(VC)funding significantly in

3、creased heading into 2026 and are expected to boost demand for lab/R&D space.3Life sciences real estate investment activity to grow in 2026Policy uncertainty lessened and capital market conditions improved in H2 2025,reigniting life sciences real estate investment.In 2026,sales activity is expected

4、to double in four of the top U.S.markets.4Historically high facility investments will boost domestic life sciences presenceLife sciences companies are making historically high facility investments to accommodate growth amid surging domestic pharmaceutical and medicine manufacturing.5Industry megatre

5、nds will influence real estate demand and activityA historically high patent cliff,the rapid pace of scientific progress and Chinas emergence as a global life sciences force will impact U.S.lab/R&D real estate in various and different ways.4CBRE RESEARCH 2026 CBRE,INC.Intelligent Investment 2026 U.S

6、.Life Sciences Trends0510152025303540Q4 2016Q4 2017Q4 2018Q4 2019Q4 2020Q4 2021Q4 2022Q4 2023Q4 2024Q4 2025Q4 2026MSFPrimary 10 MarketsTop 3 Markets(BOS,SF,SD)CAPITAL MARKETSLife Sciences Lab/R&D Space Under ConstructionConstruction activity will fall further in 2026 4CBRE RESEARCH 2025 CBRE,INC.Sou